Correlation Between BridgeBio Pharma and Cardiff Oncology
Can any of the company-specific risk be diversified away by investing in both BridgeBio Pharma and Cardiff Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BridgeBio Pharma and Cardiff Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BridgeBio Pharma and Cardiff Oncology, you can compare the effects of market volatilities on BridgeBio Pharma and Cardiff Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BridgeBio Pharma with a short position of Cardiff Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of BridgeBio Pharma and Cardiff Oncology.
Diversification Opportunities for BridgeBio Pharma and Cardiff Oncology
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between BridgeBio and Cardiff is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding BridgeBio Pharma and Cardiff Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiff Oncology and BridgeBio Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BridgeBio Pharma are associated (or correlated) with Cardiff Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiff Oncology has no effect on the direction of BridgeBio Pharma i.e., BridgeBio Pharma and Cardiff Oncology go up and down completely randomly.
Pair Corralation between BridgeBio Pharma and Cardiff Oncology
Given the investment horizon of 90 days BridgeBio Pharma is expected to under-perform the Cardiff Oncology. But the stock apears to be less risky and, when comparing its historical volatility, BridgeBio Pharma is 1.64 times less risky than Cardiff Oncology. The stock trades about -0.04 of its potential returns per unit of risk. The Cardiff Oncology is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 211.00 in Cardiff Oncology on September 6, 2024 and sell it today you would earn a total of 30.00 from holding Cardiff Oncology or generate 14.22% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
BridgeBio Pharma vs. Cardiff Oncology
Performance |
Timeline |
BridgeBio Pharma |
Cardiff Oncology |
BridgeBio Pharma and Cardiff Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BridgeBio Pharma and Cardiff Oncology
The main advantage of trading using opposite BridgeBio Pharma and Cardiff Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BridgeBio Pharma position performs unexpectedly, Cardiff Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiff Oncology will offset losses from the drop in Cardiff Oncology's long position.BridgeBio Pharma vs. Blueprint Medicines Corp | BridgeBio Pharma vs. Amylyx Pharmaceuticals | BridgeBio Pharma vs. Day One Biopharmaceuticals | BridgeBio Pharma vs. Terns Pharmaceuticals |
Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. PDS Biotechnology Corp | Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. Eyenovia |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Transaction History View history of all your transactions and understand their impact on performance |